Synthetic Toll-Like Receptor 4 Agonist Enhances Vaccine Efficacy in an Experimental Model of Toxic Shock Syndrome
- 1 November 2007
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 14 (11) , 1499-1504
Abstract
The development of new protein subunit vaccines has stimulated the search for improved adjuvants to replace traditional aluminum-containing products. We investigated the adjuvant effects of a synthetic Toll-like receptor 4 (TLR4) agonist on vaccine efficacy in an experimental model of toxic shock syndrome. The TLR4 agonist E6020 has a simplified structure consisting of a hexa-acylated acyclic backbone. The vaccine examined is a recombinantly attenuated form of staphylococcal enterotoxin B (STEBVax). Using cells stably transfected with TLRs, E6020 transduced signals only through TLR4, suggesting monospecificity, while Escherichia coli 055:B5 lipopolysaccharide activated both the TLR2/6 heterodimer and TLR4. Coadministration of E6020 with STEBVax, by the intramuscular or intranasal route, induced significant levels of immunoglobulin G (IgG) in BALB/c mice. Further, increased IgG production resulted from the combination of E6020 with aluminum hydroxide adjuvant (AH). The antibody response to the vaccine coadministered with E6020 was a mixed Th1/Th2 response, as opposed to the Th2-biased response obtained with AH. Mice vaccinated with STEBVax coadministered with AH, TLR4 agonists, or a combination of both adjuvants were protected from toxic shock. Our data demonstrate the effectiveness of the synthetic TLR4 agonist E6020 as an alternative adjuvant for protein subunit vaccines that may also be used in combination with traditional aluminum-containing adjuvants.Keywords
This publication has 25 references indexed in Scilit:
- A comprehensive map of the toll‐like receptor signaling networkMolecular Systems Biology, 2006
- Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluidVaccine, 2006
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Mini‐review Toll‐like receptors: networking for successEuropean Journal of Immunology, 2003
- Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine ModelInfection and Immunity, 2002
- The Toll receptor family and microbial recognitionTrends in Microbiology, 2000
- Development of engineered vaccines effective against structurally related bacterial superantigensVaccine, 1998
- Innate immunity: impact on the adaptive immune responseCurrent Opinion in Immunology, 1997
- Bacterial superantigens in human disease: structure, function and diversityTrends in Microbiology, 1995
- Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex moleculesNature Structural & Molecular Biology, 1995